Sanofi is offering to buy Dutch biotechnology company Kiadis for 308 million euros ($358.4 million) to boost its range of immunotherapy products.from Top Business News- News18.com https://ift.tt/3jSU8We
via IFTTT
Monday, 2 November 2020
Subscribe to:
Post Comments (Atom)
-
Theyve endured a financial crisis. Two deep recessions. Mounds of student debt. Stagnant pay. Costly health care. Dim job prospects. from ...
-
Krsnaa Diagnostics IPO Allotment: Investors can check the share allotment status in two ways a) via BSE b) via registrar’s website from To...
-
Today, market will eye global developments around the Russia-Ukriane conflict and possible new sanctions on Russia by the EU. The weekend fa...
No comments:
Post a Comment